Astute Imaging Purchases Egyptian Deep Technology AI Startup DilenyTech Astute Imaging is a provider of procedure planning and imaging-guided treatment services. DilenyTech is an Egyptian startup in deep technology that has developed innovative AI solutions for screening and diagnosing radiology.
Astute Imaging will now be able to harness the power and potential of AI to expand its offerings, develop new services, and provide innovative solutions for the medical imaging industry. “This strategic acquisition of DilenyTech will enable Astute Imaging to expedite the development of an Artificial Intelligence-driven image-guided therapy platform and add more automation to our imaging services and procedure planning solutions,” Wael Elseaidy, co-founder and CEO of Astute Imaging, stated. “Empowering our surgery planning and patient follow-up imaging platforms with AI will help our customers and medical imaging stakeholders to provide more patient-centric proactive services.” Astute Imaging, previously known as Medstreaming/M2S was spun off last month by Fivos Inc. to adopt state-of-the art AI and cloud technologies. This will allow Astute Imaging to improve its unique imaging software and provide precision medicine to healthcare providers and device manufacturers. DilenyTech developed several vendor-neutral AI proprietary technologies for radiology workflow with a special focus on women’s health. It has been able to provide its services to several top-tier healthcare companies around the world and also provided AI applications to many other healthcare organizations. “We are excited to be part of Astute Imaging’s amazing team and adopt our expertise and technologies to build reliable AI technologies for imaging-guided therapy,” said Ahmed Ehab Mahmoud, DilenyTech founder and innovation director who will be joining Astute Imaging’s founding team and managing the imaging operations. “We have applied our technologies successfully in the area of breast imaging and we look forward to expanding our AI pipeline to other imaging areas such as thyroid, liver and gynecology as well as cardiovascular 3D imaging and procedural planning. We believe Astute Imaging will be a game-changer for healthcare providers and device companies.” Astute Imaging plans to launch an AI-powered tracking app for the aorta in order to provide proactive, patient-centric services to providers. Astute Imaging plans to integrate its imaging core lab with procedure planning services with AI in order to facilitate seamless workflow and device tracking within the medical device sector. Astute Imaging will leverage its alerts and services to enable patient tracking via mobile apps, as a step closer to precision medicine. “This acquisition will help Astute Imaging to expedite the introduction of AI into its cloud-based platform for image-guided therapy and workflow automation utilizing millions of procedure data assets to drive faster and enhanced services.” Ewald de Vries, co-founder and Astute imaging CTO, indicated. “Incorporating AI into our cloud-based alert management system and creating data-driven predictive algorithms for procedure planning will make our offering very powerful and unique.
